Clinical Trials Logo

Clinical Trial Summary

Background: Accurate labeling of obstruction site on upright abdominal radiograph is a challenging task. The lack of ground truth leads to poor performance on supervised learning models. To address this issue, self-supervised learning (SSL) is proposed to classify normal, small bowel obstruction (SBO), and large bowel obstruction (LBO) radiographs using a few confirmed samples. Methods: A few number of confirmed and a large number of unlabeled radiographs were categorized based on the ground truth. The SSL model was firstly trained on the unlabeled radiographs, and then fine-tuned on the confirmed radiographs. ResNet50 and VGG16 were used for the embedded base encoders, whose weights and parameters were adjusted during training process. Furthermore, it was tested on an independent dataset, compared with supervised learning models and human interpreters. Finally, the t-SNE and Grad-CAM were used to visualize the model's interpretation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06321614
Study type Observational
Source The First Affiliated Hospital of Soochow University
Contact
Status Active, not recruiting
Phase
Start date December 31, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05066139 - Multidisciplinary Evaluation of Elderly Patients With Digestive Cancer (EPODIG-G) N/A
Recruiting NCT04475952 - Early Diagnosis of Upper Digestive Tract Disease
Completed NCT05064163 - SROI Project on the Surgical Waiting List Management System
Completed NCT03549494 - Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction Phase 2
Completed NCT03559543 - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma Phase 2
Completed NCT03723447 - Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Phase 4
Enrolling by invitation NCT01483248 - Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis Phase 1/Phase 2
Completed NCT03008460 - Efficacy, Safety and Tolerability of Eziclen®/Izinova® Versus Klean-prep® on Bowel Cleansing in Adolescents Undergoing Colonoscopy Phase 3
Active, not recruiting NCT05253859 - CFTR Modulators and Gastrointestinal Complications
Not yet recruiting NCT05636657 - Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease
Completed NCT05160077 - Optoacoustic Characterization of Postprandial Intestinal Blood Flow N/A
Recruiting NCT05401058 - Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery N/A
Completed NCT06283732 - A Clinical Study to Assess the Effect of a Supplement on Digestive Health, Overall Well-being, and Participant Experience. N/A
Not yet recruiting NCT06271538 - Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome Phase 4
Terminated NCT03594331 - Gastric Gluten-Degradation Activity of PvP001 Phase 1
Not yet recruiting NCT05405842 - Transauricular Vagal Nerve Stimulation; Functional Dyspepsia and Gastroparesis N/A
Completed NCT02785783 - Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection N/A
Completed NCT00072943 - A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease Phase 2
Completed NCT03037385 - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Phase 1/Phase 2
Completed NCT05827679 - Creation and Validation of a Clinical Evaluation Scale for Abdominal Condition of the Premature (ECAP)